相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
AR-H 053591
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
246146-55-4
- 规格:
5 mg/10 mg/25 mg/50 mg
| 规格: | 5 mg | 产品价格: | ¥1500.0 |
|---|---|---|---|
| 规格: | 10 mg | 产品价格: | ¥2400.0 |
| 规格: | 25 mg | 产品价格: | ¥4800.0 |
| 规格: | 50 mg | 产品价格: | ¥7700.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
BIIE-0246
CAS No. : 246146-55-4
MCE 国际站:BIIE-0246
产品活性:BIIE-0246 是一种有效的、非肽神经肽 Y (NPY) Y2 受体的高度选择性拮抗剂,其 IC50 值为 15 nM。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:Neuropeptide Y Receptor
In Vitro: Receptor binding assays in HEK 293 cells transfected with the rat Y2 receptor cDNA demonstrate that BIIE-0246 competes with high affinity (IC50=15±3 nM) against specific [125I]PYY3-36 binding sites. In contrast, BIIE-0246, at concentrations up to 10 μM, fails to compete for significant amounts of specific [125I]GR231118, [125I]hPP and [125I][Leu31, Pro34]PYY binding sites in HEK 293 cells transfected with the rat Y1, Y4 or Y5 receptor cDNA, respectively.
In Vivo: On chow diet, genetically obese NPY mice show increased gain in body weight and adiposity. Treatment with BIIE-0246 promotes body weight gain in both genotypes after 4.5 weeks, and already at 2 weeks. BIIE-0246 has no significant effect on fat mass gain. In DIO, BIIE-0246 has different effects on body weight and composition depending on the genotype (treatment×genotype interaction in body weight P<0.05, in fat mass P<0.001 and in lean mass P<0.05). In DIO-WT group, post hoc analysis reveals increased body weight and fat mass gain, and a tendency to decrease lean mass gain. In DIO-NPY, BIIE-0246 inhibits fat mass gain (P=0.05). Interestingly, increased cholesterol levels are detected also in WT mice treated with BIIE-0246 for 2 weeks, but not in the 4.5-week cohort. In DIO-NPY mice in both treatment groups, cholesterol levels correlate positively with body fat mass (DIO-NPY vehicle P<0.01; DIO-NPY BIIE-0246 P<0.001), but not in any other group, and the slope of the regression curve of cholesterol and fat mass is significantly decreased in BIIE-0246-treated DIO-NPY group when compared with vehicle-treated group.
相关产品:Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | Anti-diabetic Compound Library | Endocrinology Compound Library | Neurotransmitter Receptor Compound Library | Anti-Obesity Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | BIBO3304 TFA | HT-2157 | Galanin (1-30), human | SHA 68 | MK-0557 | Neuropeptide Y (human) (TFA) | Spexin | BIBP3226 TFA | JNJ-31020028 | Peptide YY (PYY) (3-36), porcine TFA | CGP71683 hydrochloride | Galanin Receptor Ligand M35 | BMS-193885 | RF9 | L 152804 | Neuropeptide Y (3-36) (human, rat) | RFRP-3(human) | [Leu31,Pro34]-Neuropeptide Y(human,rat) TFA | Pancreatic Polypeptide, human | Velneperit | CYM 9484 | Galnon TFA | RFRP-1(human) | [Leu31,Pro34]-Neuropeptide Y (porcine) | BIIE-0246 hydrochloride | CART(55-102)(human) | M617 TFA | Neuropeptide S(Mouse) | Galanin (1-16), mouse, porcine, rat TFA
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















